Cargando…
Improvement of Quality of Life (QOL) in Osteoporotic Patients by Elcatonin Treatment: A Trial Taking the Participants’ Preference into Account
Osteoporosis is associated with compromised quality of life (QOL), to which pain has the most important contribution. Elcatonin, a derivative of calcitonin, is widely used in the treatment of osteoporosis in two ways. One is as the inhibitor of osteoclastic bone resorption. The other is for osteopor...
Autores principales: | Yoh, K., Uzawa, T., Orito, T., Tanaka, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738553/ https://www.ncbi.nlm.nih.gov/pubmed/23946680 http://dx.doi.org/10.4137/JCM.S8291 |
Ejemplares similares
-
Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures
por: Wang, Baohui, et al.
Publicado: (2022) -
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
por: Okamoto, Hiroaki, et al.
Publicado: (2020) -
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009) -
Multi-Component Structure of Roland-Morris Disability Questionnaire (RDQ), a Lumbago-Specific QOL (Quality of Life) Measure
por: Yoh, K., et al.
Publicado: (2011) -
Elcatonin attenuates disuse osteoporosis after fracture fixation of tubular bone in rats
por: Ji, Zhe, et al.
Publicado: (2015)